Author/Authors :
Moeinzadeh, Firouzeh Isfahan Kidney Diseases Research Center- Isfahan University of Medical Sciences, Isfahan, Iran , Dezfouli, Majid Department of Internal Medicine - Isfahan University of Medical Sciences, Isfahan, Iran , Naimi, Azar Department of Pathology - Isfahan University of Medical Sciences, Isfahan, Iran , Shahidi,Shahrzad Isfahan Kidney Diseases Research Center- Isfahan University of Medical Sciences, Isfahan, Iran , Moradi, Hazhir Isfahan Kidney Diseases Research Center- Isfahan University of Medical Sciences, Isfahan, Iran
Abstract :
During the COVID-19 pandemic, we had a 25 years old male case
without any underlying disease or history of autoimmune disease
in COVID-19 Clinic, Isfahan, Iran. He presented with arthralgia
and weakness so we started COVID-19 therapeutic regimen. In his
hospitalization, creatinine increases and abnormalities in random
urine sediment was seen. Methylprednisolone and cyclophosphamide
were prescribed due to suspected glomerulonephritis. After renal
biopsy the diagnose was confirmed as crescentic proliferative
glomerulonephritis. The patient also, underwent plasmapheresis
and intravenous immunoglobulin injection. He was discharged
healthy without development of new pulmonary symptoms despite
immunosuppressive treatment.
